Panacea Life Sciences HoldingsPLSH +3.64% PB Ratio is 0.25 as of Jun. 24, 2026, which is 38% below its 10-year median of 0.40. The stock has 6 warning signs investors should review. Among 922 Drug Manufacturers companies, Panacea Life Sciences Holdings ranks better than 97.94% on this metric.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Panacea Life Sciences Holdings PB Ratio Related Terms
Panacea Life Sciences Holdings PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Panacea Life Sciences Holdings's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Panacea Life Sciences Holdings PB Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Panacea Life Sciences Holdings's PB Ratio distribution charts can be found below:
* The bar in red indicates where Panacea Life Sciences Holdings's PB Ratio falls into.
Panacea Life Sciences Holdings PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Panacea Life Sciences Holdings (PLSH) has a PB Ratio of 0.25 as of Jun. 24, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Panacea Life Sciences Holdings and its competitors. This is 38% below median its historical median of 0.40. Over the past decade, Panacea Life Sciences Holdings' PB Ratio has ranged from 0.14 to 2.96. According to the industry distribution chart, Panacea Life Sciences Holdings ranks #19 out of 922 companies in the Drug Manufacturers industry, placing it in the top 2.1%.
Is Panacea Life Sciences Holdings' PB Ratio too high?
Panacea Life Sciences Holdings' current PB Ratio of 0.25 is 38% below median its 10-year median of 0.40. Over the past 10 years, this metric has ranged from a low of 0.14 to a high of 2.96. The Drug Manufacturers industry median PB Ratio is 1.88. Panacea Life Sciences Holdings' value of 0.25 is 86.7% below this industry median. Based on the distribution chart, Panacea Life Sciences Holdings ranks #19 out of 922 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers.
How does Panacea Life Sciences Holdings' PB Ratio compare to NPHC and OWPC?
According to the Drug Manufacturers industry distribution chart, Panacea Life Sciences Holdings ranks #19 out of 922 companies for PB Ratio. This places Panacea Life Sciences Holdings in the top 2% of its industry — outperforming the majority of peers. The industry median PB Ratio is 1.88. Panacea Life Sciences Holdings' value of 0.25 is 86.7% below this benchmark. Historically, Panacea Life Sciences Holdings' own PB Ratio has ranged from 0.14 to 2.96 over the past decade. While the company's 10-year median is 0.40 vs. the industry median of 1.88, Panacea Life Sciences Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Drug Manufacturers company?
The median PB Ratio among Drug Manufacturers companies is 1.88, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Panacea Life Sciences Holdings's current PB Ratio of 0.25 is 86.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Panacea Life Sciences Holdings and its competitors. For the Drug Manufacturers industry, the median PB Ratio is 1.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Panacea Life Sciences Holdings's current PB Ratio is 0.25, which is 38% below median its own 10-year median of 0.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Panacea Life Sciences Holdings stock overvalued right now?
Panacea Life Sciences Holdings (PLSH) has a current PB Ratio of 0.25. The current PB Ratio is 0.25, which is 38% below median its 10-year median of 0.40 and 86.7% below the Drug Manufacturers industry median of 1.88. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Panacea Life Sciences Holdings (PLSH), the current PB Ratio is 0.25 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Panacea Life Sciences Holdings Business Description
Panacea Life Sciences Holdings Inc is a holding company organized as a plant-based natural health ingredient and product company, specializing in the development, manufacturing, research, and distribution of products and rapidly growing natural health and wellness market segment for both humans and animals. The company also offers the purest natural remedies within its branded product lines for every aspect of life: PANA Health, PANA Beauty, PANA Sport, PANA Pet, PANA Pure and PANA Life.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PLSH has been successfully added to your 